FGF9-Associated Multiple Synostoses Syndrome Type 3 in a Multigenerational Family

Genes (Basel). 2023 Mar 15;14(3):724. doi: 10.3390/genes14030724.

Abstract

Multiple synostoses syndrome (OMIM: #186500, #610017, #612961, #617898) is a genetically heterogeneous group of autosomal dominant diseases characterized by abnormal bone unions. The joint fusions frequently involve the hands, feet, elbows or vertebrae. Pathogenic variants in FGF9 have been associated with multiple synostoses syndrome type 3 (SYNS3). So far, only five different missense variants in FGF9 that cause SYNS3 have been reported in 18 affected individuals. Unlike other multiple synostoses syndromes, conductive hearing loss has not been reported in SYNS3. In this report, we describe the clinical and selected radiological findings in a large multigenerational family with a novel missense variant in FGF9: c.430T>C, p.(Trp144Arg). We extend the phenotypic spectrum of SYNS3 by suggesting that cleft palate and conductive hearing loss are part of the syndrome and highlight the high degree of intrafamilial phenotypic variability. These findings should be considered when counseling affected individuals.

Keywords: FGF9; SYNS3; cleft palate; craniosynostoses; fusion of interphalangeal joints; human genetics; multiple synostoses syndrome type 3; whole exome sequencing.

Publication types

  • Case Reports

MeSH terms

  • Extended Family
  • Fibroblast Growth Factor 9
  • Hearing Loss, Conductive* / genetics
  • Humans
  • Mutation, Missense
  • Syndrome
  • Synostosis*

Substances

  • FGF9 protein, human
  • Fibroblast Growth Factor 9

Supplementary concepts

  • Multiple Synostoses Syndrome 3

Grants and funding

This research received no external funding.